Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	79.79	6.37	10.72	29.47	19.38	9.95
Short-Term Investments	7.5	52.86	2.41	1.51	1.08	1.09
Trading Asset Securities	-	-	8.08	3.08	0.58	0.58
Cash & Short-Term Investments	87.29	59.23	21.21	34.05	21.04	11.62
Cash Growth	404.51%	179.31%	-37.73%	61.84%	81.16%	-62.41%
Accounts Receivable	668.45	1,771	648.49	345.6	902.73	410.75
Other Receivables	-	-	-	-	0.16	0.18
Receivables	676.45	1,776	650.95	347.11	903.79	418.19
Inventory	2,253	2,399	1,750	1,501	464.6	675.75
Restricted Cash	-	0.5	0.38	3.38	0.26	0.25
Other Current Assets	841.89	45.02	149.49	276.34	136.81	195.01
Total Current Assets	3,859	4,280	2,572	2,162	1,526	1,301
Property, Plant & Equipment	650.88	524.89	461.53	386.26	322.82	303.25
Long-Term Investments	9.17	12.43	4.66	0.03	0.03	0.03
Other Intangible Assets	4.4	4.27	4.2	3.08	0.56	0.27
Other Long-Term Assets	118.59	52.98	33.61	21.32	19.98	11.83
Total Assets	4,642	4,874	3,076	2,573	1,870	1,616
Accounts Payable	994.5	1,448	629.47	593.43	486.17	599.61
Accrued Expenses	-	60.62	27.98	27.47	24.45	20.53
Short-Term Debt	-	1,506	867.6	677.09	186.19	167.37
Current Portion of Long-Term Debt	1,408	69.21	59.52	33.98	-	-
Current Portion of Leases	-	12.37	-	-	-	-
Current Income Taxes Payable	130.11	71.16	55.35	42.9	27.91	11.26
Other Current Liabilities	151.29	113.84	28.36	21.7	12.79	65.8
Total Current Liabilities	2,684	3,281	1,668	1,397	737.5	864.56
Long-Term Debt	302.26	96.13	127.98	154.4	420.39	291.11
Pension & Post-Retirement Benefits	-	18.56	11.62	9.97	10.03	10.01
Long-Term Deferred Tax Liabilities	44.84	44.84	41.37	38.43	14.31	13.77
Other Long-Term Liabilities	38.05	19.77	12.04	9.67	7.05	6.04
Total Liabilities	3,069	3,460	1,861	1,609	1,189	1,185
Common Stock	47.22	47.22	46.99	45.32	44.33	39.9
Additional Paid-In Capital	-	738.23	714.27	549.69	454.12	271.55
Retained Earnings	-	628.39	437.73	285.48	180.04	119.26
Comprehensive Income & Other	1,525	-0	15.72	83.27	2.13	-
Total Common Equity	1,572	1,414	1,215	963.76	680.61	430.7
Shareholders' Equity	1,572	1,414	1,215	963.76	680.61	430.7
Total Liabilities & Equity	4,642	4,874	3,076	2,573	1,870	1,616
Total Debt	1,710	1,684	1,055	865.47	606.59	458.48
Net Cash (Debt)	-1,623	-1,625	-1,034	-831.41	-585.54	-446.87
Net Cash Per Share	-349.62	-349.98	-222.73	-185.67	-141.03	-112.00
Filing Date Shares Outstanding	4.72	4.72	4.7	4.53	4.43	3.99
Total Common Shares Outstanding	4.72	4.72	4.7	4.53	4.43	3.99
Working Capital	1,175	998.56	903.72	765.54	788.99	436.25
Book Value Per Share	333.11	299.43	258.50	212.64	153.54	107.96
Tangible Book Value	1,568	1,410	1,211	960.68	680.05	430.43
Tangible Book Value Per Share	332.18	298.53	257.60	211.96	153.42	107.89
Land	-	5.24	5.24	5.24	5.24	5.24
Buildings	-	235.73	220.93	210.02	210.02	200.76
Machinery	-	547.57	391.07	289.59	198.63	167.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.